PLRX / Pliant Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Pliant Therapeutics, Inc.
US ˙ NasdaqGS ˙ US7291391057

Deler fremragende 61,920,249 shares
Insideraktier5.772.653 shares
Insider ejerskab9,32 %
Total Insiders16
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
1426 out of 10951

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
1424 out of 10791

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Pliant Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Suzanne Louise Bruhn Director - [D] 70.162 70.162
Lily Cheung Chief Human Resource Officer - [O] 44.847 44.847
Bernard Coulie President and CEO, Director - [D] [O] 505.601 505.601
Keith Lamont Cummings Chief Financial Officer - [O] 297.214 297.214
John T Curnutte Director - [D] 58.556 58.556
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Neil Exter Director - [D] 0 0
Charles J Homcy Director - [D] 146.756 146.756
Barbara Howes Chief Human Resource Officer - [O] 24.799 24.799
Hoyoung Huh Director - [D] 239.619 239.619
Hans Hull Chief Business Officer - [O] 251.708 251.708
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Minnie Kuo Chief Operating Officer - [O] 37.806 37.806
Eric Lefebvre Chief Medical Officer - [O] 240.224 240.224
Mike Ouimette General Counsel & Corp. Sec'y - [O] 105.544 105.544
David E I Pyott 26.573
Redmile Group, LLC 10% Owner - [10%] 1.910.657 1.910.657
Third Rock Ventures III, L.P. 10% Owner - [10%] 1.839.160 1.839.160

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i PLRX / Pliant Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PLRX / Pliant Therapeutics, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i PLRX / Pliant Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2026-01-20 Cheung Lily 7.534 1,2800 7.534 1,2800 9.644 16 1.0900 -1.431 -14,84
2026-01-20 Kuo Minnie 6.917 1,2800 6.917 1,2800 8.854
2026-01-20 Coulie Bernard 89.375 1,2800 89.375 1,2800 114.400
2026-01-20 Cummings Keith Lamont 24.002 1,2800 24.002 1,2800 30.723
2025-01-17 Ouimette Mike 13.270 11,2011 13.270 11,2011 148.639
2025-01-17 Lefebvre Eric 18.478 11,2011 18.478 11,2011 206.974
2025-01-17 Hull Hans 15.936 11,2011 15.936 11,2011 178.501
2025-01-17 Cummings Keith Lamont 20.148 11,2011 20.148 11,2011 225.680
2025-01-17 Coulie Bernard 52.419 11,2011 52.419 11,2011 587.150

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PLRX / Pliant Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-01-22 2026-01-20 4 Cummings Keith Lamont PLRX Common Stock S - Sale D 1,2800 -24.002 -31 297.214
2026-01-22 2026-01-20 4 Coulie Bernard PLRX Common Stock S - Sale D 1,2800 -89.375 -114 505.601
2026-01-22 2026-01-20 4 Kuo Minnie PLRX Common Stock S - Sale D 1,2800 -6.917 -9 37.806
2026-01-22 2026-01-20 4 Cheung Lily PLRX Common Stock S - Sale D 1,2800 -7.534 -10 44.847
2025-12-22 3 Kuo Minnie PLRX Common Stock D 44.723
2025-01-27 2025-01-23 4 Cheung Lily PLRX Common Stock A - Award D 25.875 50.425
2025-01-27 2025-01-23 4 Ouimette Mike PLRX Common Stock A - Award D 35.000 105.544
2025-01-27 2025-01-23 4 Hull Hans PLRX Common Stock A - Award D 40.150 251.708
2025-01-27 2025-01-23 4 Lefebvre Eric PLRX Common Stock A - Award D 45.650 240.224
2025-01-27 2025-01-23 4 Cummings Keith Lamont PLRX Common Stock A - Award D 56.650 319.258
2025-01-27 2025-01-23 4 Coulie Bernard PLRX Common Stock A - Award D 162.500 593.017
2025-01-22 2025-01-17 4 Coulie Bernard PLRX Common Stock S - Sale D 11,2011 -52.419 -587 430.517
2025-01-22 2025-01-17 4 Cummings Keith Lamont PLRX Common Stock S - Sale D 11,2011 -20.148 -226 262.608
2025-01-22 2025-01-17 4 Hull Hans PLRX Common Stock S - Sale D 11,2011 -15.936 -179 211.558
2025-01-22 2025-01-17 4 Lefebvre Eric PLRX Common Stock S - Sale D 11,2011 -18.478 -207 194.574
2025-01-22 2025-01-17 4 Cheung Lily PLRX Common Stock S - Sale D 11,2011 -3.740 -42 24.550
2025-01-22 2025-01-22 4 Ouimette Mike PLRX Common Stock S - Sale D 10,9934 -10.230 -112 70.544
2025-01-22 2025-01-17 4 Ouimette Mike PLRX Common Stock S - Sale D 11,2011 -13.270 -149 80.774
2024-07-12 2024-07-10 4 Lefebvre Eric PLRX Common Stock S - Sale D 11,5600 -12.319 -142 213.052
2024-07-12 2024-07-10 4 Hull Hans PLRX Common Stock S - Sale D 11,5600 -9.900 -114 227.494
2024-07-12 2024-07-10 4 Cummings Keith Lamont PLRX Common Stock S - Sale D 11,5600 -10.911 -126 282.115
2024-07-12 2024-07-10 4 Coulie Bernard PLRX Common Stock S - Sale D 11,5600 -38.710 -447 482.936
2024-07-12 2024-07-10 4 Ouimette Mike PLRX Common Stock S - Sale D 11,5600 -7.656 -89 94.044
2024-07-11 2024-07-09 4 Lefebvre Eric PLRX Common Stock A - Award D 24.063 225.371
2024-07-11 2024-07-09 4 Hull Hans PLRX Common Stock A - Award D 19.337 237.394
2024-07-11 2024-07-09 4 Cummings Keith Lamont PLRX Common Stock A - Award D 21.313 293.026
2024-07-11 2024-07-09 4 Coulie Bernard PLRX Common Stock A - Award D 75.625 521.646
2024-07-11 2024-07-09 4 Ouimette Mike PLRX Common Stock A - Award D 14.954 101.700
2024-05-06 2024-05-02 4 Cummings Keith Lamont PLRX Common Stock M - Exercise D 2,0800 21.000 44 271.713
2024-01-24 2024-01-23 4 Coulie Bernard PLRX Common Stock A - Award D 128.150 444.532
2024-01-24 2024-01-23 4 Cummings Keith Lamont PLRX Common Stock A - Award D 55.250 249.855
2024-01-24 2024-01-23 4 Cheung Lily PLRX Common Stock A - Award D 26.000 26.795
2024-01-24 2024-01-23 4 Ouimette Mike PLRX Common Stock A - Award D 31.500 86.746
2024-01-24 2024-01-23 4 Lefebvre Eric PLRX Common Stock A - Award D 42.900 199.820
2024-01-24 2024-01-23 4 Hull Hans PLRX Common Stock A - Award D 31.500 216.569
2024-01-19 2024-01-17 4 Lefebvre Eric PLRX Common Stock S - Sale D 17,2300 -10.295 -177 156.920
2024-01-19 2024-01-17 4 Coulie Bernard PLRX Common Stock S - Sale D 17,2300 -25.721 -443 316.382
2024-01-19 2024-01-17 4 Hull Hans PLRX Common Stock S - Sale D 17,2300 -9.786 -169 185.069
2024-01-19 2024-01-17 4 Cummings Keith Lamont PLRX Common Stock S - Sale D 17,2300 -9.781 -169 194.605
2024-01-19 2024-01-17 4 Ouimette Mike PLRX Common Stock S - Sale D 17,2300 -5.197 -90 55.246
2023-08-07 2023-08-04 4 Hull Hans PLRX Common Stock S - Sale D 20,0100 -20.050 -401 194.855
2023-08-07 2023-08-04 4 Hull Hans PLRX Common Stock M - Exercise D 2,0800 8.791 18 214.905
2023-08-07 2023-08-03 4 Hull Hans PLRX Common Stock S - Sale D 20,0000 1.800 36 206.114
2023-08-07 2023-08-03 4 Hull Hans PLRX Common Stock M - Exercise D 2,0800 1.800 4 207.914
2023-08-07 2023-08-03 4 Hull Hans PLRX Common Stock S - Sale D 20,0000 -13.069 -261 206.114
2023-07-21 2023-07-20 4 Ouimette Mike PLRX Common Stock S - Sale D 17,5500 -4.755 -83 60.443
2023-07-19 2023-07-17 4 Ouimette Mike PLRX Common Stock S - Sale D 18,0091 -12.778 -230 65.198
2023-07-19 2023-07-17 4 Lefebvre Eric PLRX Common Stock S - Sale D 18,0091 -22.321 -402 167.215
2023-07-19 2023-07-17 4 Hull Hans PLRX Common Stock S - Sale D 18,0091 -17.937 -323 219.183
2023-07-19 2023-07-17 4 Cummings Keith Lamont PLRX Common Stock S - Sale D 18,0091 -19.771 -356 203.999
2023-07-19 2023-07-17 4 Coulie Bernard PLRX Common Stock S - Sale D 18,0091 -70.150 -1.263 342.103
2023-07-18 2023-07-14 4 Ouimette Mike PLRX Common Stock A - Award D 27.187 77.976
2023-07-18 2023-07-14 4 Hull Hans PLRX Common Stock A - Award D 35.156 237.120
2023-07-18 2023-07-14 4 Lefebvre Eric PLRX Common Stock A - Award D 43.750 189.536
2023-07-18 2023-07-14 4 Cummings Keith Lamont PLRX Common Stock A - Award D 38.750 223.770
2023-07-18 2023-07-14 4 Coulie Bernard PLRX Common Stock A - Award D 137.500 412.253
2023-06-14 2023-06-13 4 Cummings Keith Lamont PLRX Common Stock M - Exercise D 2,0800 30.750 64 185.020
2023-06-12 2023-06-09 4 Cummings Keith Lamont PLRX Common Stock M - Exercise D 2,0800 5.800 12 154.270
2023-04-03 2023-04-03 4 Ouimette Mike PLRX Common Stock S - Sale D 27,4550 -200 -5 50.789
2023-04-03 2023-04-03 4 Ouimette Mike PLRX Common Stock S - Sale D 26,7371 -2.677 -72 50.989
2023-04-03 2023-03-30 4 Ouimette Mike PLRX Common Stock S - Sale D 26,5209 -4.874 -129 53.666
2023-04-03 2023-03-30 4 Lefebvre Eric PLRX Common Stock S - Sale D 26,5209 -11.245 -298 145.786
2023-04-03 2023-03-30 4 Hull Hans PLRX Common Stock S - Sale D 26,5209 -9.036 -240 201.964
2023-04-03 2023-03-30 4 Cummings Keith Lamont PLRX Common Stock S - Sale D 26,5209 -9.960 -264 148.470
2023-04-03 2023-03-30 4 Coulie Bernard PLRX Common Stock S - Sale D 26,5209 -35.339 -937 274.753
2023-03-31 2023-03-29 4 Ouimette Mike PLRX Common Stock A - Award D 13.593 58.540
2023-03-31 2023-03-29 4 Lefebvre Eric PLRX Common Stock A - Award D 21.874 157.031
2023-03-31 2023-03-29 4 Hull Hans PLRX Common Stock A - Award D 17.578 211.000
2023-03-31 2023-03-29 4 Cummings Keith Lamont PLRX Common Stock A - Award D 19.375 158.430
2023-03-31 2023-03-29 4 Coulie Bernard PLRX Common Stock A - Award D 68.749 310.092
2023-02-06 2023-02-03 4 Coulie Bernard PLRX Common Stock S - Sale D 34,0768 -5.262 -179 240.112
2023-02-06 2023-02-03 4 Coulie Bernard PLRX Common Stock S - Sale D 33,3629 -9.738 -325 245.374
2023-02-06 2023-02-03 4 Coulie Bernard PLRX Common Stock M - Exercise D 6,2200 15.000 93 255.112
2023-02-06 2023-02-02 4 Coulie Bernard PLRX Common Stock S - Sale D 34,9566 -1.605 -56 240.112
2023-02-06 2023-02-02 4 Coulie Bernard PLRX Common Stock S - Sale D 34,1265 -13.395 -457 241.717
2023-02-06 2023-02-02 4 Coulie Bernard PLRX Common Stock M - Exercise D 6,2200 15.000 93 255.112
2023-02-01 2023-02-01 4 Coulie Bernard PLRX Common Stock S - Sale D 35,5548 -105 -4 240.112
2023-02-01 2023-02-01 4 Coulie Bernard PLRX Common Stock S - Sale D 34,7780 -5.440 -189 240.217
2023-02-01 2023-02-01 4 Coulie Bernard PLRX Common Stock S - Sale D 34,1450 -9.455 -323 245.657
2023-02-01 2023-02-01 4 Coulie Bernard PLRX Common Stock M - Exercise D 6,2200 15.000 93 255.112
2023-02-01 2023-01-31 4 Coulie Bernard PLRX Common Stock S - Sale D 34,9170 -15.000 -524 240.112
2023-02-01 2023-01-31 4 Coulie Bernard PLRX Common Stock M - Exercise D 6,2200 4.461 28 255.112
2023-02-01 2023-01-31 4 Coulie Bernard PLRX Common Stock M - Exercise D 2,0800 10.539 22 250.651
2023-02-01 2023-01-30 4 Coulie Bernard PLRX Common Stock S - Sale D 34,6570 -3.605 -125 240.112
2023-02-01 2023-01-30 4 Coulie Bernard PLRX Common Stock S - Sale D 33,9778 -11.395 -387 243.717
2023-02-01 2023-01-30 4 Coulie Bernard PLRX Common Stock M - Exercise D 2,0800 15.000 31 255.112
2023-01-27 2023-01-25 4 Hull Hans PLRX Common Stock A - Award D 54.000 192.191
2023-01-27 2023-01-25 4 Lefebvre Eric PLRX Common Stock A - Award D 57.000 133.926
2023-01-27 2023-01-25 4 Cummings Keith Lamont PLRX Common Stock A - Award D 54.000 138.424
2023-01-27 2023-01-25 4 Ouimette Mike PLRX Common Stock A - Award D 39.000 44.947
2023-01-27 2023-01-27 4 Coulie Bernard PLRX Common Stock S - Sale I 36,6400 -221 -8 409.317
2023-01-27 2023-01-27 4 Coulie Bernard PLRX Common Stock S - Sale I 35,0913 -9.779 -343 409.538
2023-01-27 2023-01-27 4 Coulie Bernard PLRX Common Stock S - Sale D 36,0589 -6.302 -227 240.112
2023-01-27 2023-01-27 4 Coulie Bernard PLRX Common Stock S - Sale D 35,4157 -8.698 -308 246.414
2023-01-27 2023-01-27 4 Coulie Bernard PLRX Common Stock M - Exercise D 2,0800 15.000 31 255.112
2023-01-27 2023-01-26 4 Coulie Bernard PLRX Common Stock S - Sale I 35,0950 -15.000 -526 419.317
2023-01-27 2023-01-26 4 Coulie Bernard PLRX Common Stock S - Sale D 35,2911 -15.000 -529 240.112
2023-01-27 2023-01-26 4 Coulie Bernard PLRX Common Stock M - Exercise D 2,0800 15.000 31 255.112
2023-01-27 2023-01-25 4 Coulie Bernard PLRX Common Stock A - Award D 146.300 240.112
2023-01-25 2023-01-23 4 Cummings Keith Lamont PLRX Common Stock S - Sale D 35,0000 -30.000 -1.050 84.424
2023-01-25 2023-01-23 4 Cummings Keith Lamont PLRX Common Stock M - Exercise D 6,2200 17.500 109 114.424
2023-01-25 2023-01-23 4 Cummings Keith Lamont PLRX Common Stock M - Exercise D 2,0800 12.500 26 96.924
2023-01-25 2023-01-23 4 Ouimette Mike PLRX Common Stock S - Sale D 34,1939 -20.000 -684 5.947
2023-01-25 2023-01-23 4 Ouimette Mike PLRX Common Stock M - Exercise D 24,3200 10.000 243 25.947
2023-01-25 2023-01-23 4 Ouimette Mike PLRX Common Stock M - Exercise D 11,8600 10.000 119 15.947
2023-01-25 2023-01-23 4 Lefebvre Eric PLRX Common Stock S - Sale D 34,4834 -67.500 -2.328 76.926
2023-01-25 2023-01-25 4 Coulie Bernard PLRX Common Stock S - Sale D 33,2897 -1.696 -56 93.812
2023-01-25 2023-01-25 4 Coulie Bernard PLRX Common Stock S - Sale D 32,4006 -13.304 -431 95.508
2023-01-25 2023-01-25 4 Coulie Bernard PLRX Common Stock M - Exercise D 2,0800 15.000 31 108.812
2023-01-25 2023-01-24 4 Coulie Bernard PLRX Common Stock S - Sale D 30,8926 -15.000 -463 93.812
2023-01-25 2023-01-24 4 Coulie Bernard PLRX Common Stock M - Exercise D 2,0800 15.000 31 108.812
2023-01-25 2023-01-23 4 Coulie Bernard PLRX Common Stock S - Sale I 35,0000 -15.000 -525 434.317
2023-01-25 2023-01-23 4 Coulie Bernard PLRX Common Stock S - Sale D 34,9288 -4.850 -169 93.812
2023-01-25 2023-01-23 4 Coulie Bernard PLRX Common Stock S - Sale D 33,7106 -10.150 -342 98.662
2023-01-25 2023-01-23 4 Coulie Bernard PLRX Common Stock M - Exercise D 2,0800 15.000 31 108.812
2023-01-09 2023-01-09 4 Coulie Bernard PLRX Common Stock S - Sale D 19,1658 -5.000 -96 93.812
2023-01-09 2023-01-09 4 Coulie Bernard PLRX Common Stock M - Exercise D 2,0800 5.000 10 98.812
2023-01-09 2023-01-06 4 Coulie Bernard PLRX Common Stock S - Sale D 19,0389 -15.000 -286 93.812
2023-01-09 2023-01-06 4 Coulie Bernard PLRX Common Stock M - Exercise D 2,0800 15.000 31 108.812
2023-01-05 2023-01-04 4 Coulie Bernard PLRX Common Stock S - Sale D 19,0627 -15.000 -286 93.812
2023-01-05 2023-01-04 4 Coulie Bernard PLRX Common Stock M - Exercise D 2,0800 15.000 31 108.812
2023-01-05 2023-01-03 4 Coulie Bernard PLRX Common Stock S - Sale D 19,3301 -15.000 -290 93.812
2023-01-05 2023-01-03 4 Coulie Bernard PLRX Common Stock M - Exercise D 2,0800 15.000 31 108.812
2022-12-27 2022-12-22 4 Cummings Keith Lamont PLRX Common Stock M - Exercise D 2,0800 4.000 8 84.424
2022-12-23 2022-12-22 4 Ouimette Mike PLRX Common Stock S - Sale D 19,3753 -2.928 -57 5.947
2022-12-21 2022-12-20 4 Coulie Bernard PLRX Common Stock S - Sale D 19,1024 -34.212 -654 93.812
2022-12-21 2022-12-19 4 Coulie Bernard PLRX Common Stock A - Award D 68.751 128.024
2022-12-21 2022-12-20 4 Ouimette Mike PLRX Common Stock S - Sale D 19,1024 -4.719 -90 8.875
2022-12-21 2022-12-19 4 Ouimette Mike PLRX Common Stock A - Award D 13.594 13.594
2022-12-21 2022-12-20 4 Lefebvre Eric PLRX Common Stock S - Sale D 19,1024 -10.887 -208 144.426
2022-12-21 2022-12-19 4 Lefebvre Eric PLRX Common Stock A - Award D 21.876 155.313
2022-12-21 2022-12-20 4 Hull Hans PLRX Common Stock S - Sale D 19,1024 -8.748 -167 138.191
2022-12-21 2022-12-19 4 Hull Hans PLRX Common Stock A - Award D 17.578 146.939
2022-12-21 2022-12-20 4 Cummings Keith Lamont PLRX Common Stock S - Sale D 19,1024 -9.643 -184 80.424
2022-12-21 2022-12-19 4 Cummings Keith Lamont PLRX Common Stock A - Award D 19.375 90.067
2022-12-01 2022-11-29 4 Third Rock Ventures III, L.P. PLRX Common Stock J - Other D -2.000.000 1.839.160
2022-10-27 2022-10-25 4 Lefebvre Eric PLRX Common Stock S - Sale D 25,0482 -5.000 -125 133.437
2022-09-22 2022-09-20 4 Third Rock Ventures III, L.P. PLRX Common Stock J - Other D -2.000.000 3.839.160
2022-09-14 2022-09-12 4 Coulie Bernard PLRX Common Stock S - Sale D 22,5445 -12.502 -282 59.273
2022-09-14 2022-09-12 4 Coulie Bernard PLRX Common Stock M - Exercise D 2,0800 12.502 26 71.775
2022-07-13 2022-07-12 4 Coulie Bernard PLRX Common Stock S - Sale D 22,5000 -12.498 -281 59.273
2022-07-13 2022-07-12 4 Coulie Bernard PLRX Common Stock M - Exercise D 2,0800 12.498 26 71.771
2022-07-13 2022-07-11 4 Coulie Bernard PLRX Common Stock S - Sale D 22,5000 -15.000 -338 59.273
2022-07-13 2022-07-11 4 Coulie Bernard PLRX Common Stock M - Exercise D 2,0800 15.000 31 74.273
2022-07-13 2022-07-11 4 Lefebvre Eric PLRX Common Stock S - Sale D 20,0000 -3.000 -60 138.436
2022-02-02 2022-01-26 4 Ouimette Mike PLRX Stock Option (right to buy) A - Award D 11,86 87.000 87.000
2022-02-02 2022-01-26 4 Cummings Keith Lamont PLRX Stock Option (right to buy) A - Award D 11,86 124.000 124.000
2022-02-02 2022-01-26 4 Hull Hans PLRX Stock Option (right to buy) A - Award D 11,86 112.500 112.500
2022-02-02 2022-01-26 4 Lefebvre Eric PLRX Stock Option (right to buy) A - Award D 11,86 140.000 140.000
2022-02-02 2022-01-26 4 Coulie Bernard PLRX Stock Option (right to buy) A - Award D 11,86 440.000 440.000
2021-09-03 2021-09-03 4 Cummings Keith Lamont PLRX Stock Option (right to buy) M - Exercise D 2,08 -20.000 150.097
2021-09-03 2021-09-03 4 Cummings Keith Lamont PLRX Common Stock M - Exercise D 2,0800 20.000 42 67.621
2021-07-01 2021-06-29 4/A PYOTT DAVID E I PLRX Stock Option (right to buy) A - Award D 28,20 13.286 13.286
2021-06-30 2021-06-29 4 Shah Smital PLRX Stock Option (right to buy) A - Award D 28,20 13.286 13.286
2021-06-30 2021-06-29 4 PYOTT DAVID E I PLRX Stock Option (right to buy) A - Award D 28,20 13.286 13.286
2021-06-30 2021-06-29 4 Huh Hoyoung PLRX Stock Option (right to buy) A - Award D 28,20 13.286 13.286
2021-06-30 2021-06-29 4 HOMCY CHARLES J PLRX Stock Option (right to buy) A - Award D 28,20 13.286 13.286
2021-06-30 2021-06-29 4 Exter Neil PLRX Stock Option (right to buy) A - Award D 28,20 13.286 13.286
2021-06-30 2021-06-29 4 Curnutte John T PLRX Stock Option (right to buy) A - Award D 28,20 13.286 13.286
2021-06-30 2021-06-29 4 CROWELL GAYLE A PLRX Stock Option (right to buy) A - Award D 28,20 13.286 13.286
2021-06-30 2021-06-29 4 Bruhn Suzanne Louise PLRX Stock Option (right to buy) A - Award D 28,20 13.286 13.286
2021-06-22 2021-06-18 4 Lefebvre Eric PLRX Common Stock S - Sale D 30,2300 -22 -1 137.080
2021-06-22 2021-06-18 4 Lefebvre Eric PLRX Common Stock S - Sale D 29,4308 -3.728 -110 137.102
2021-06-22 2021-06-18 4 Lefebvre Eric PLRX Common Stock S - Sale D 28,6215 -8.750 -250 140.830
2021-06-15 2021-06-14 4 Coulie Bernard PLRX Common Stock S - Sale I 33,6888 -243 -8 449.317
2021-06-15 2021-06-14 4 Coulie Bernard PLRX Common Stock S - Sale I 32,9827 -3.757 -124 449.560
2021-05-28 2021-05-26 4 Hull Hans PLRX Stock Option (right to buy) M - Exercise D 2,08 -4.500 12.979
2021-05-28 2021-05-26 4 Hull Hans PLRX Common Stock M - Exercise D 2,0800 4.500 9 125.246
2021-05-17 2021-05-14 4 Coulie Bernard PLRX Common Stock S - Sale I 29,2758 -503 -15 453.317
2021-05-17 2021-05-14 4 Coulie Bernard PLRX Common Stock S - Sale I 28,5281 -2.997 -85 453.820
2021-04-15 2021-04-14 4 Coulie Bernard PLRX Common Stock S - Sale I 30,3318 -3.500 -106 456.817
2021-04-15 2021-04-13 4 Coulie Bernard PLRX Stock Option (right to buy) M - Exercise D 2,08 -6.000 337.380
2021-04-15 2021-04-13 4 Coulie Bernard PLRX Common Stock M - Exercise D 2,0800 6.000 12 54.840
2021-03-19 2021-03-18 4 Lefebvre Eric PLRX Common Stock S - Sale D 39,7799 -1.135 -45 149.580
2021-03-19 2021-03-18 4 Lefebvre Eric PLRX Common Stock S - Sale D 39,3777 -11.365 -448 150.715
2021-03-17 2021-03-15 4 Coulie Bernard PLRX Common Stock S - Sale I 39,6876 -178 -7 460.317
2021-03-17 2021-03-15 4 Coulie Bernard PLRX Common Stock S - Sale I 38,7505 -2.000 -78 460.495
2021-03-17 2021-03-15 4 Coulie Bernard PLRX Common Stock S - Sale I 38,0254 -1.322 -50 462.495
2021-03-05 2021-03-05 4 Cummings Keith Lamont PLRX Stock Option (right to buy) M - Exercise D 2,08 -20.000 170.097
2021-03-05 2021-03-05 4 Cummings Keith Lamont PLRX Common Stock M - Exercise D 2,0800 20.000 42 47.621
2021-02-17 2021-02-16 4 Coulie Bernard PLRX Common Stock S - Sale I 34,0700 -200 -7 463.817
2021-02-17 2021-02-16 4 Coulie Bernard PLRX Common Stock S - Sale I 32,8657 -2.100 -69 464.017
2021-02-17 2021-02-16 4 Coulie Bernard PLRX Common Stock S - Sale I 32,0999 -1.200 -39 466.117
2021-01-26 2021-01-23 4 Ouimette Mike PLRX Stock Option (right to buy) A - Award D 26,50 15.520 15.520
2021-01-26 2021-01-23 4 Hull Hans PLRX Stock Option (right to buy) A - Award D 26,50 62.250 62.250
2021-01-26 2021-01-23 4 Howes Barbara PLRX Stock Option (right to buy) A - Award D 26,50 42.500 42.500
2021-01-26 2021-01-23 4 Coulie Bernard PLRX Stock Option (right to buy) A - Award D 26,50 250.000 250.000
2021-01-26 2021-01-23 4 Lefebvre Eric PLRX Stock Option (right to buy) A - Award D 26,50 73.250 73.250
2021-01-26 2021-01-23 4 Cummings Keith Lamont PLRX Stock Option (right to buy) A - Award D 26,50 74.250 74.250
2021-01-15 2021-01-14 4 Coulie Bernard PLRX Common Stock S - Sale I 27,2143 -630 -17 467.317
2021-01-15 2021-01-14 4 Coulie Bernard PLRX Common Stock S - Sale I 26,1952 -2.870 -75 467.947
2021-01-13 2021-01-12 4 PYOTT DAVID E I PLRX Stock Option (right to buy) A - Award D 27,71 26.573 26.573
2021-01-04 2020-12-30 4 Hull Hans PLRX Stock Option (right to buy) M - Exercise D 2,08 -3.500 17.479
2021-01-04 2020-12-30 4 Hull Hans PLRX Common Stock M - Exercise D 2,0800 3.500 7 120.746
2020-12-23 2020-12-21 4 Cummings Keith Lamont PLRX Stock Option (right to buy) M - Exercise D 2,08 -4.500 190.097
2020-12-23 2020-12-21 4 Cummings Keith Lamont PLRX Common Stock M - Exercise D 2,0800 4.500 9 27.621
2020-12-21 2020-12-18 4 Lefebvre Eric PLRX Common Stock S - Sale D 26,9800 -5.712 -154 162.080
2020-12-21 2020-12-18 4 Lefebvre Eric PLRX Common Stock S - Sale D 26,1700 -6.788 -178 167.792
2020-12-16 2020-12-14 4 Coulie Bernard PLRX Common Stock S - Sale I 27,8587 -337 -9 470.817
2020-12-16 2020-12-14 4 Coulie Bernard PLRX Common Stock S - Sale I 27,3164 -3.163 -86 471.154
2020-12-02 2020-12-01 4 Cummings Keith Lamont PLRX Stock Option (right to buy) M - Exercise D 6,22 -7.143 35.698
2020-12-02 2020-12-01 4 Cummings Keith Lamont PLRX Stock Option (right to buy) M - Exercise D 2,08 -11.591 194.597
2020-12-02 2020-12-01 4 Cummings Keith Lamont PLRX Common Stock S - Sale D 30,7200 -846 -26 23.121
2020-12-02 2020-12-01 4 Cummings Keith Lamont PLRX Common Stock S - Sale D 30,2100 -14.901 -450 24
2020-12-02 2020-12-01 4 Cummings Keith Lamont PLRX Common Stock S - Sale D 29,0700 -1.848 -54 38.868
2020-12-02 2020-12-01 4 Cummings Keith Lamont PLRX Common Stock S - Sale D 28,2400 -1.139 -32 40.716
2020-12-02 2020-12-01 4 Cummings Keith Lamont PLRX Common Stock M - Exercise D 6,2200 7.143 44 41.855
2020-12-02 2020-12-01 4 Cummings Keith Lamont PLRX Common Stock M - Exercise D 2,0800 11.591 24 34.712
2020-10-13 2020-10-09 4 Ouimette Mike PLRX Stock Option (right to buy) A - Award D 24,32 108.240 108.240
2020-06-09 2020-06-05 4 Hull Hans PLRX Series C Preferred Stock C - Conversion I -27.322 0
2020-06-09 2020-06-05 4 Hull Hans PLRX Series B Preferred Stock C - Conversion D -36.319 0
2020-06-09 2020-06-05 4 Hull Hans PLRX Common Stock C - Conversion I 3.821 3.821
2020-06-09 2020-06-05 4 Hull Hans PLRX Common Stock C - Conversion D 5.079 117.246
2020-06-09 2020-03-31 4 Hull Hans PLRX Stock Option (right to buy) A - Award D 6,22 70.352 70.352
2020-06-09 2020-02-28 4 Hull Hans PLRX Series C Preferred Stock A - Award I 13,0845 27.322 357 27.322
2020-06-09 2020-06-05 4 Huh Hoyoung PLRX Series A Preferred Stock C - Conversion I 1.000.000 0
2020-06-09 2020-06-05 4 Huh Hoyoung PLRX Common Stock C - Conversion I 139.860 239.619
2020-06-09 2020-06-05 4 Cummings Keith Lamont PLRX Series C Preferred Stock C - Conversion D -27.322 0
2020-06-09 2020-06-05 4 Cummings Keith Lamont PLRX Common Stock C - Conversion D 3.821 23.121
2020-06-09 2020-04-30 4 Cummings Keith Lamont PLRX Stock Option (right to buy) M - Exercise D 2,08 -19.300 206.188
2020-06-09 2020-04-30 4 Cummings Keith Lamont PLRX Common Stock M - Exercise D 2,0800 19.300 40 19.300
2020-06-09 2020-03-31 4 Cummings Keith Lamont PLRX Stock Option (right to buy) A - Award D 6,22 42.841 42.841
2020-06-09 2020-02-28 4 Cummings Keith Lamont PLRX Series C Preferred Stock A - Award D 13,0845 27.322 357 27.322
2020-06-09 2020-06-05 4 Exter Neil PLRX Series A Preferred Stock C - Conversion I 0 0
2020-06-09 2020-06-05 4 Exter Neil PLRX Common Stock C - Conversion I 0 0
2020-06-09 2020-03-31 4 Exter Neil PLRX Stock Option (right to buy) A - Award D 6,22 26.573 26.573
2020-06-09 2020-06-05 4 Third Rock Ventures III, L.P. See Footnotes PLRX Series A Preferred Stock C - Conversion I -15.250.000 0
2020-06-09 2020-06-05 4 Third Rock Ventures III, L.P. PLRX Series A Preferred Stock C - Conversion D -39.750.000 0
2020-06-09 2020-06-05 4 Third Rock Ventures III, L.P. See Footnotes PLRX Common Stock C - Conversion I 2.132.867 2.132.867
2020-06-09 2020-06-05 4 Third Rock Ventures III, L.P. PLRX Common Stock C - Conversion D 5.559.440 5.839.160
2020-06-09 2020-06-05 4 Howes Barbara PLRX Series C Preferred Stock C - Conversion D -27.322 0
2020-06-09 2020-06-05 4 Howes Barbara PLRX Common Stock C - Conversion D 3.821 24.799
2020-06-09 2020-03-31 4 Howes Barbara PLRX Stock Option (right to buy) A - Award D 6,22 7.584 7.584
2020-06-09 2020-02-27 4 Howes Barbara PLRX Series C Preferred Stock A - Award D 13,0845 27.322 357 27.322
2020-06-09 2020-06-05 4 Coulie Bernard PLRX Series B Preferred Stock C - Conversion I -181.594 0
2020-06-09 2020-06-05 4 Coulie Bernard PLRX Common Stock C - Conversion I 25.397 474.317
2020-06-09 2020-04-30 4 Coulie Bernard PLRX Stock Option (right to buy) M - Exercise D 2,08 -48.227 343.380
2020-06-09 2020-04-30 4 Coulie Bernard PLRX Stock Option (right to buy) M - Exercise D 6,22 -613 376.723
2020-06-09 2020-04-30 4 Coulie Bernard PLRX Common Stock M - Exercise D 2,0800 48.227 100 48.840
2020-06-09 2020-04-30 4 Coulie Bernard PLRX Common Stock M - Exercise D 6,2200 613 4 613
2020-06-09 2020-03-31 4 Coulie Bernard PLRX Stock Option (right to buy) A - Award D 6,22 377.336 377.336
2020-06-09 2020-06-05 4 Redmile Group, LLC PLRX Series C Preferred Stock C - Conversion I -13.661.202 0
2020-06-09 2020-06-05 4 Redmile Group, LLC PLRX Common Stock C - Conversion I 1.910.657 1.910.657
2020-06-02 3 Curnutte John T PLRX Common Stock D 58.556
2020-06-02 3 Curnutte John T PLRX Common Stock D 58.556
2020-06-02 3 Curnutte John T PLRX Common Stock D 58.556
2020-06-02 3 Bruhn Suzanne Louise PLRX Common Stock D 70.162
2020-06-02 3 Bruhn Suzanne Louise PLRX Common Stock D 70.162
2020-06-02 3 Bruhn Suzanne Louise PLRX Common Stock D 70.162
2020-06-02 3 Howes Barbara PLRX Common Stock D 41.956
2020-06-02 3 Howes Barbara PLRX Common Stock D 41.956
2020-06-02 3 Howes Barbara PLRX Common Stock D 41.956
2020-06-02 3 Hull Hans PLRX Common Stock I 154.122
2020-06-02 3 Hull Hans PLRX Common Stock I 154.122
2020-06-02 3 Hull Hans PLRX Common Stock D 252.304
2020-06-02 3 Hull Hans PLRX Common Stock I 154.122
2020-06-02 3 Hull Hans PLRX Common Stock I 154.122
2020-06-02 3 Hull Hans PLRX Common Stock I 154.122
2020-06-02 3 Hull Hans PLRX Common Stock D 252.304
2020-06-02 3 Hull Hans PLRX Common Stock D 252.304
2020-06-02 3 Hull Hans PLRX Common Stock I 154.122
2020-06-02 3 TRV GP IV, LLC PLRX Common Stock D 559.440
2020-06-02 3 TRV GP IV, LLC PLRX Common Stock D 559.440
2020-06-02 3 TRV GP IV, LLC PLRX Common Stock D 559.440
2020-06-02 3 TRV GP IV, LLC PLRX Common Stock D 559.440
2020-06-02 3 TRV GP IV, LLC PLRX Common Stock D 559.440
2020-06-02 3 TRV GP IV, LLC PLRX Common Stock D 559.440
2020-06-02 3 TRV GP IV, LLC PLRX Common Stock D 559.440
2020-06-02 3 TRV GP IV, LLC PLRX Common Stock D 559.440
2020-06-02 3 TRV GP IV, LLC PLRX Common Stock D 559.440
2020-06-02 3 TRV GP IV, LLC PLRX Common Stock D 559.440
2020-06-02 3 TRV GP IV, LLC PLRX Common Stock D 559.440
2020-06-02 3 Cummings Keith Lamont PLRX Common Stock D 38.600
2020-06-02 3 Cummings Keith Lamont PLRX Common Stock D 38.600
2020-06-02 3 Cummings Keith Lamont PLRX Common Stock D 38.600
2020-06-02 3 Coulie Bernard PLRX Common Stock D 546.600
2020-06-02 3 Coulie Bernard PLRX Common Stock D 546.600
2020-06-02 3 Coulie Bernard PLRX Common Stock I 946.680
2020-06-02 3 Coulie Bernard PLRX Common Stock D 546.600
2020-06-02 3 Coulie Bernard PLRX Common Stock I 946.680
2020-06-02 3 Coulie Bernard PLRX Common Stock I 946.680
2020-06-02 3 HOMCY CHARLES J PLRX Common Stock D 146.756
2020-06-02 3 HOMCY CHARLES J PLRX Common Stock D 146.756
2020-06-02 3 HOMCY CHARLES J PLRX Common Stock D 146.756
2020-06-02 3 Lefebvre Eric PLRX Common Stock D 349.160
2020-06-02 3 Lefebvre Eric PLRX Common Stock D 349.160
2020-06-02 3 Lefebvre Eric PLRX Common Stock D 349.160
2020-06-02 3 Exter Neil PLRX Common Stock I 0
2020-06-02 3 Huh Hoyoung PLRX Common Stock I 199.518
2020-06-02 3 Huh Hoyoung PLRX Common Stock I 199.518
2020-06-02 3 Huh Hoyoung PLRX Common Stock I 199.518
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:9PT 1,00 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista